Bio-Rad Laboratories, Inc. (BIO) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.26B |
| Enterprise Value | 9.26B |
| P/E Ratio | 46.23 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 2.95 |
| Price/Book Ratio | 1.11 |
| Enterprise/Revenue | 3.28 |
| Enterprise/EBITDA | 18.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 2.58B |
| Revenue/Share | 96.07 |
| Gross Profit | 1.34B |
| EBITDA | 1.25B |
| Net Income | 759.9M |
| Diluted EPS | 27.87 |
Balance Sheet
| Total Cash | 1.56B |
| Total Cash/Share | 58.04 |
| Total Debt | 1.38B |
| Total Debt/Equity | 0.2 |
| Current Ratio | 3.21 |
| Book Value Per Share | 254.15 |
Price History
| 52-Week Change | 19.91 |
| 52-Week High | 343.12 |
| 52-Week Low | 228.4 |
| Moving Average 50 Days | 283.39 |
| Moving Average 200 Days | 293.72 |
Statistics
| Average Volume | 377,880 |
| Shares Outstanding | 27.04M |
| % Held by Institutions | 74.06 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.2 |
| Last Split Factor | 2:1 |
| Last Split Date | March 08, 2002 |
AD
